{"id":3769,"date":"2023-07-21T16:55:25","date_gmt":"2023-07-21T23:55:25","guid":{"rendered":"https:\/\/grail.com\/?page_id=3769"},"modified":"2025-10-17T15:22:46","modified_gmt":"2025-10-17T22:22:46","slug":"press-releases","status":"publish","type":"page","link":"https:\/\/grail.com\/press-releases\/","title":{"rendered":"Press Releases"},"content":{"rendered":"\n \n
\n
\n
\n
\n
\n \"\"
\n \n <\/div>\n <\/div>\n <\/div>\n
\n
Featured News<\/div>\n
\n GRAIL PATHFINDER 2 Results Show Galleri\u00ae\u00a0Multi-Cancer Early Detection Blood Test Increased Cancer Detection More Than Seven-Fold When Added to USPSTF A and B Recommended Screenings \n <\/div>\n\n

\n More Than Half of Cancers Detected by Galleri Were Early Stage Approximately Three-Quarters of Galleri-Detected Cancers Do Not Have Recommended Screenings PATHFINDER 2 is the Largest U.S. Multi-Cancer Early Detection (MCED) Interventional Study in the Cancer Screening Population MENLO PARK, Calif. \u2013 Oct. 17, 2025 \u2014 GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission […] <\/p>\n \n View Press Release<\/a>\n <\/div>\n <\/div>\n <\/div>\n<\/div>\n\n\n\n\n

Press Releases<\/h2>\n\n\n
\n
\n
\n
\n
\n \n Press Releases <\/div>\n \n <\/div>\n
\n
\n
\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL to Present at 7th Annual Wolfe Research Healthcare Conference <\/div>\n
\n View Press Release\n <\/div>\n
\n 11\/04\/2025 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL to Announce Third Quarter 2025 Financial Results <\/div>\n
\n View Press Release\n <\/div>\n
\n 10\/29\/2025 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL, Inc. Announces $325.0 Million Private Placement Financing <\/div>\n
\n View Press Release\n <\/div>\n
\n 10\/20\/2025 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL and University of Oxford Present Long-Term Data From the SYMPLIFY Study Evaluating the Galleri\u00ae Multi-Cancer Early Detection Test in Symptomatic Individuals at the Early Detection of Cancer Conference (EDCC) <\/div>\n
\n View Press Release\n <\/div>\n
\n 10\/20\/2025 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL PATHFINDER 2 Results Show Galleri\u00ae\u00a0Multi-Cancer Early Detection Blood Test Increased Cancer Detection More Than Seven-Fold When Added to USPSTF A and B Recommended Screenings <\/div>\n
\n View Press Release\n <\/div>\n
\n 10\/17\/2025 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
Samsung and GRAIL Announce Strategic Collaboration\u00a0 to Bring GRAIL\u2019s Galleri\u00ae Multi-Cancer Early Detection Test to Asia <\/div>\n
\n View Press Release\n <\/div>\n
\n 10\/16\/2025 <\/div>\n <\/div>\n <\/a>\n \n <\/div>\n
\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL to Present New Galleri\u00ae Data From More Than 32,000 Participants Across the PATHFINDER 2, SYMPLIFY and REFLECTION Studies at ESMO Congress 2025 and EDCC <\/div>\n
\n View Press Release\n <\/div>\n
\n 09\/23\/2025 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL to Present at Bernstein Insights: Healthcare Leaders and Disruptors \u2013 2nd Annual Healthcare Forum <\/div>\n
\n View Press Release\n <\/div>\n
\n 09\/10\/2025 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) <\/div>\n
\n View Press Release\n <\/div>\n
\n 08\/29\/2025 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL to Present at Morgan Stanley 23rd Annual Global Healthcare Conference <\/div>\n
\n View Press Release\n <\/div>\n
\n 08\/26\/2025 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Reports Second Quarter 2025 Financial Results <\/div>\n
\n View Press Release\n <\/div>\n
\n 08\/12\/2025 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL to Present at Canaccord Genuity 45th Annual Growth Conference <\/div>\n
\n View Press Release\n <\/div>\n
\n 07\/30\/2025 <\/div>\n <\/div>\n <\/a>\n \n <\/div>\n
\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL to Announce Second Quarter 2025 Financial Results <\/div>\n
\n View Press Release\n <\/div>\n
\n 07\/29\/2025 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Announces Positive Top-Line Results From The Galleri\u00ae PATHFINDER 2 Registrational Study <\/div>\n
\n View Press Release\n <\/div>\n
\n 06\/18\/2025 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) <\/div>\n
\n View Press Release\n <\/div>\n
\n 05\/30\/2025 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL to Present at Jefferies Global Healthcare Conference 2025 <\/div>\n
\n View Press Release\n <\/div>\n
\n 05\/21\/2025 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Reports First Quarter 2025 Financial Results <\/div>\n
\n View Press Release\n <\/div>\n
\n 05\/13\/2025 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL and athenahealth Team Up to Offer Healthcare Providers Streamlined Ordering of GRAIL\u2019s Galleri\u00ae Multi-Cancer Early Detection (MCED) Test <\/div>\n
\n View Press Release\n <\/div>\n
\n 05\/12\/2025 <\/div>\n <\/div>\n <\/a>\n \n <\/div>\n
\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL to Announce First Quarter 2025 Financial Results <\/div>\n
\n View Press Release\n <\/div>\n
\n 04\/29\/2025 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL to Present New Data on Galleri\u00ae and its Methylation Platform at American Association for Cancer Research (AACR) Annual Meeting <\/div>\n
\n View Press Release\n <\/div>\n
\n 04\/22\/2025 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) <\/div>\n
\n View Press Release\n <\/div>\n
\n 02\/26\/2025 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Partners With Actress Kate Walsh for Generation Possible to Raise Awareness of Multi-Cancer Early Detection Testing <\/div>\n
\n View Press Release\n <\/div>\n
\n 02\/25\/2025 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL to Present at TD Cowen 45th Annual Health Care Conference <\/div>\n
\n View Press Release\n <\/div>\n
\n 02\/21\/2025 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Reports Fourth Quarter and Full Year 2024 Financial Results <\/div>\n
\n View Press Release\n <\/div>\n
\n 02\/20\/2025 <\/div>\n <\/div>\n <\/a>\n \n <\/div>\n
\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL to Announce Fourth Quarter 2024 Financial Results <\/div>\n
\n View Press Release\n <\/div>\n
\n 02\/12\/2025 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL and Quest Diagnostics Provide GRAIL\u2019s Galleri\u00ae Multi-Cancer Early Detection (MCED) Test Through the Quest Diagnostics Test Ordering System <\/div>\n
\n View Press Release\n <\/div>\n
\n 02\/12\/2025 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
Patient Reported Outcomes for GRAIL\u2019s Galleri\u00ae Multi-Cancer Early Detection Blood Test Published in Lancet Oncology <\/div>\n
\n View Press Release\n <\/div>\n
\n 01\/13\/2025 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL to Present at the 43rd Annual J.P. Morgan Healthcare Conference <\/div>\n
\n View Press Release\n <\/div>\n
\n 12\/18\/2024 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) <\/div>\n
\n View Press Release\n <\/div>\n
\n 12\/03\/2024 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL to Participate in Upcoming Investor Conferences <\/div>\n
\n View Press Release\n <\/div>\n
\n 11\/19\/2024 <\/div>\n <\/div>\n <\/a>\n \n <\/div>\n
\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Announces First Patient Tested With Blood-Based Assay in Global Phase 3 Adjuvant Lung Cancer Study <\/div>\n
\n View Press Release\n <\/div>\n
\n 11\/18\/2024 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Reports Third Quarter 2024 Financial Results <\/div>\n
\n View Press Release\n <\/div>\n
\n 11\/12\/2024 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum <\/div>\n
\n View Press Release\n <\/div>\n
\n 11\/04\/2024 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL to Announce Third Quarter 2024 Financial Results <\/div>\n
\n View Press Release\n <\/div>\n
\n 10\/29\/2024 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Presents Initial Results From REFLECTION Real-World Evidence Study of Galleri\u00ae Multi-Cancer Early Detection (MCED) Test at the Early Detection of Cancer Conference <\/div>\n
\n View Press Release\n <\/div>\n
\n 10\/23\/2024 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Appoints Sarah Krevans to Board of Directors <\/div>\n
\n View Press Release\n <\/div>\n
\n 10\/21\/2024 <\/div>\n <\/div>\n <\/a>\n \n <\/div>\n
\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) <\/div>\n
\n View Press Release\n <\/div>\n
\n 08\/30\/2024 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
Results of GRAIL\u2019s Galleri\u00ae Multi-Cancer Early Detection Blood Test in Prostate Cancer Published in JCO Precision Oncology <\/div>\n
\n View Press Release\n <\/div>\n
\n 08\/29\/2024 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference <\/div>\n
\n View Press Release\n <\/div>\n
\n 08\/21\/2024 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Reports Second Quarter 2024 Financial Results and Provides a Strategic Update <\/div>\n
\n View Press Release\n <\/div>\n
\n 08\/13\/2024 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL to Announce Second Quarter 2024 Financial Results <\/div>\n
\n View Press Release\n <\/div>\n
\n 07\/31\/2024 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Announces First Participant Enrolled in REACH Study Evaluating Clinical Impact of Galleri\u00ae Multi-Cancer Early Detection (MCED) Test in the Medicare Population <\/div>\n
\n View Press Release\n <\/div>\n
\n 07\/18\/2024 <\/div>\n <\/div>\n <\/a>\n \n <\/div>\n
\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Advances the Galleri\u00ae Registrational Clinical Trial Program <\/div>\n
\n View Press Release\n <\/div>\n
\n 07\/15\/2024 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL to Begin Trading on the Nasdaq Stock Exchange <\/div>\n
\n View Press Release\n <\/div>\n
\n 06\/24\/2024 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
Illumina Board of Directors approves spin-off of GRAIL; declares spin-off dividend of GRAIL shares <\/div>\n
\n View Press Release\n <\/div>\n
\n 06\/03\/2024 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL to Host Capital Markets Day <\/div>\n
\n View Press Release\n <\/div>\n
\n 05\/13\/2024 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
Illumina publicly files Form 10 registration statement ahead of planned divestiture of GRAIL <\/div>\n
\n View Press Release\n <\/div>\n
\n 05\/06\/2024 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Presents New Data on Galleri\u00ae and Its Methylation Platform at the Annual American Association for Cancer Research (AACR) Meeting <\/div>\n
\n View Press Release\n <\/div>\n
\n 03\/27\/2024 <\/div>\n <\/div>\n <\/a>\n \n <\/div>\n
\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Announces Novel Risk Classification Test to be Used in Lung Cancer Study <\/div>\n
\n View Press Release\n <\/div>\n
\n 03\/18\/2024 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
Curative Insurance Company Adds GRAIL\u2019s Galleri\u00ae Test to Member Benefits for Multi-Cancer Early Detection <\/div>\n
\n View Press Release\n <\/div>\n
\n 02\/01\/2024 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Partners With Professional Golfers Steve Stricker and Juli Inkster to Raise Awareness of Multi-Cancer Early Detection\u00a0at Second Annual Galleri Classic PGA TOUR Champions Tournament <\/div>\n
\n View Press Release\n <\/div>\n
\n 01\/30\/2024 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
BeniComp to Offer GRAIL\u2019s Multi-Cancer Early Detection Test for Employee Health Screening <\/div>\n
\n View Press Release\n <\/div>\n
\n 01\/11\/2024 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
Validation Data On A Novel Prognostic Test Developed By GRAIL In Stage I Lung Cancer Presented At North America Conference On Lung Cancer <\/div>\n
\n View Press Release\n <\/div>\n
\n 12\/06\/2023 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL To Initiate REACH Study To Evaluate Clinical Impact Of Galleri\u00ae Multi-Cancer Early Detection (MCED) Test Among The Medicare Population <\/div>\n
\n View Press Release\n <\/div>\n
\n 11\/20\/2023 <\/div>\n <\/div>\n <\/a>\n \n <\/div>\n
\n \n
\n \"Img\"\n <\/div>\n
\n
HCA Healthcare and GRAIL Collaborate to Advance Comprehensive Cancer Care with Multi-Cancer Early Detection Screening\u00a0 <\/div>\n
\n View Press Release\n <\/div>\n
\n 10\/17\/2023 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
Final Results From PATHFINDER Study of GRAIL\u2019s Multi-Cancer Early Detection Blood Test Published in The Lancet <\/div>\n
\n View Press Release\n <\/div>\n
\n 10\/05\/2023 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
Point32Health and GRAIL Expand Pilot to Access Galleri\u00ae Multi-Cancer Early Detection Blood Test \u00a0\u00a0\u00a0\u00a0\u00a0 <\/div>\n
\n View Press Release\n <\/div>\n
\n 09\/28\/2023 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
Whitman-Walker Institute, Cancer Support Community and GRAIL Collaborate On Research Aimed at Advancing Health Equity in Cancer Screening and Care through Multi-Cancer Early Detection <\/div>\n
\n View Press Release\n <\/div>\n
\n 08\/23\/2023 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
The Lancet Oncology Publishes Results from SYMPLIFY, The First Prospective Study of a Multi-Cancer Early Detection Test in a Symptomatic Patient Population <\/div>\n
\n View Press Release\n <\/div>\n
\n 06\/20\/2023 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Presents Real-World Experience With The Galleri\u00ae Multi-Cancer Early Detection Test At 2023 ASCO Annual Meeting <\/div>\n
\n View Press Release\n <\/div>\n
\n 06\/03\/2023 <\/div>\n <\/div>\n <\/a>\n \n <\/div>\n
\n \n
\n \"Img\"\n <\/div>\n
\n
New PATHFINDER Study Analysis Demonstrates Efficient Diagnostic Resolution Following Multi-Cancer Early Detection Testing <\/div>\n
\n View Press Release\n <\/div>\n
\n 06\/03\/2023 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL and University of Oxford to Present Results From First Prospective Study of Multi-Cancer Early Detection in a Symptomatic Patient Population at 2023 ASCO Annual Meeting <\/div>\n
\n View Press Release\n <\/div>\n
\n 06\/01\/2023 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
Grail to Present New Multi-Cancer Early Detection Data at the 2023 ASCO Annual Meeting <\/div>\n
\n View Press Release\n <\/div>\n
\n 05\/22\/2023 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Presents Positive Analytical Validation Data on its Methylation-Based Post-Diagnostic Cancer Research Solution at American Association for Cancer Research (AACR) Annual Meeting 2023 <\/div>\n
\n View Press Release\n <\/div>\n
\n 04\/19\/2023 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
FirstHealth of the Carolinas to Offer GRAIL\u2019s Galleri\u00ae, a Multi-Cancer Early Detection Blood Test <\/div>\n
\n View Press Release\n <\/div>\n
\n 04\/18\/2023 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Presents New Data Demonstrating That Methylation Assay Detects Residual Hematologic Cancer After Treatment at American Association for Cancer Research Annual Meeting 2023 <\/div>\n
\n View Press Release\n <\/div>\n
\n 04\/17\/2023 <\/div>\n <\/div>\n <\/a>\n \n <\/div>\n
\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Showcases Methylation Platform Performance Across Cancer Continuum with New Data at American Association for Cancer Research (AACR) Annual Meeting <\/div>\n
\n View Press Release\n <\/div>\n
\n 04\/11\/2023 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
Providence and GRAIL Expand Partnership to Increase Access to Galleri\u00ae Multi-Cancer Early Detection Screening <\/div>\n
\n View Press Release\n <\/div>\n
\n 04\/04\/2023 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
John Hancock expands access to Galleri\u00ae, GRAIL\u2019s breakthrough cancer screening technology <\/div>\n
\n View Press Release\n <\/div>\n
\n 02\/23\/2023 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Teams Up with Professional Golfers David Duval and Juli Inkster to Raise Awareness of Multi-Cancer Early Detection <\/div>\n
\n View Press Release\n <\/div>\n
\n 02\/22\/2023 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Introduces State-of-the-Art Methylation-Based Solution to Accelerate Cancer Research in the Post-Diagnosis Setting <\/div>\n
\n View Press Release\n <\/div>\n
\n 01\/09\/2023 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
The Galleri Classic Announces Six Coachella Valley-Based Charitable Partners in its Mission to Combat Cancer <\/div>\n
\n View Press Release\n <\/div>\n
\n 12\/21\/2022 <\/div>\n <\/div>\n <\/a>\n \n <\/div>\n
\n \n
\n \"Img\"\n <\/div>\n
\n
Point32Health and GRAIL Expand Galleri\u00ae Multi-Cancer Early Detection Blood Test Pilot to Harvard Pilgrim Health Care Members on the Maine Health Insurance Marketplace <\/div>\n
\n View Press Release\n <\/div>\n
\n 12\/15\/2022 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL CCGA Discovery Results Published in Cancer Cell Reveal Methylation as Promising DNA Hallmark for Multi-Cancer Early Detection <\/div>\n
\n View Press Release\n <\/div>\n
\n 11\/17\/2022 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL and Carrum Health Partner to Include Galleri\u00ae as Part of Comprehensive Cancer Care Offering to Employers <\/div>\n
\n View Press Release\n <\/div>\n
\n 10\/13\/2022 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
Henry Ford Health First in Michigan to Offer Multi-Cancer Early Detection Blood Test <\/div>\n
\n View Press Release\n <\/div>\n
\n 09\/22\/2022 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
John Hancock Becomes First Life Insurance Carrier to Offer Access to GRAIL\u2019s Multi-Cancer Early Detection Test to Customers <\/div>\n
\n View Press Release\n <\/div>\n
\n 09\/20\/2022 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Announces Final Results From the PATHFINDER Multi-Cancer Early Detection Screening Study at ESMO Congress 2022 <\/div>\n
\n View Press Release\n <\/div>\n
\n 09\/11\/2022 <\/div>\n <\/div>\n <\/a>\n \n <\/div>\n
\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL to Present Final Multi-Cancer Early Detection Data from the Interventional PATHFINDER Study at ESMO Congress 2022 <\/div>\n
\n View Press Release\n <\/div>\n
\n 09\/08\/2022 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL and National Health Service (NHS) England Complete Enrollment of 140,000 Participants in Largest Study of Multi-Cancer Early Detection Test <\/div>\n
\n View Press Release\n <\/div>\n
\n 07\/18\/2022 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
Mercy Offers New GRAIL Blood Test to Detect 50+ Types of Cancer <\/div>\n
\n View Press Release\n <\/div>\n
\n 07\/12\/2022 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
Community Health Network and GRAIL Partner to Offer Galleri\u00ae Multi-Cancer Early Detection Test in Central Indiana <\/div>\n
\n View Press Release\n <\/div>\n
\n 06\/28\/2022 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL and Fountain Health Insurance Partner to Provide Coverage of Galleri\u00ae Multi-Cancer Early Detection Test <\/div>\n
\n View Press Release\n <\/div>\n
\n 06\/21\/2022 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL and England\u2019s National Health Service (NHS) Present Trial Design for Largest Study of Multi-Cancer Early Detection Test at ASCO Annual Meeting <\/div>\n
\n View Press Release\n <\/div>\n
\n 06\/06\/2022 <\/div>\n <\/div>\n <\/a>\n \n <\/div>\n
\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL and Ochsner Health Launch New Initiatives to Improve Cancer Detection Rates in Louisiana <\/div>\n
\n View Press Release\n <\/div>\n
\n 06\/03\/2022 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Announces Strategic Collaboration with AstraZeneca to Develop Companion Diagnostic Tests to Enable the Treatment of Early-Stage Cancer <\/div>\n
\n View Press Release\n <\/div>\n
\n 06\/02\/2022 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Announces Collaboration with U.S. Department of Veterans Affairs and the Veterans Health Foundation to Evaluate Galleri\u00ae Multi-Cancer Early Detection Test <\/div>\n
\n View Press Release\n <\/div>\n
\n 05\/31\/2022 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL and Intermountain Healthcare Expand Partnership to Offer Galleri\u00ae Multi-Cancer Early Detection Blood Test to Eligible Patients in Utah <\/div>\n
\n View Press Release\n <\/div>\n
\n 05\/17\/2022 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
PGA TOUR Champions and GRAIL Announce The Galleri\u00ae Classic <\/div>\n
\n View Press Release\n <\/div>\n
\n 04\/19\/2022 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL and Point32Health Collaborate to Offer Galleri\u00ae Multi-Cancer Early Detection Blood Test <\/div>\n
\n View Press Release\n <\/div>\n
\n 02\/15\/2022 <\/div>\n <\/div>\n <\/a>\n \n <\/div>\n
\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Statement on President Biden\u2019s Bold Initiative to Reignite the Cancer Moonshot <\/div>\n
\n View Press Release\n <\/div>\n
\n 02\/02\/2022 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
Knight Cancer Institute at Oregon Health & Science University to Offer the Galleri\u00ae Multi-Cancer Early Detection Test <\/div>\n
\n View Press Release\n <\/div>\n
\n 01\/10\/2022 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL and Premier\u2019s PINC AI\u2122 Partner to Support Patient Access to Galleri\u00ae Multi-Cancer Early Detection Blood Test <\/div>\n
\n View Press Release\n <\/div>\n
\n 01\/10\/2022 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Announces Partnership with Alignment Health Plan as First Medicare Advantage Plan to Offer Galleri\u00ae Multi-Cancer Early Detection Blood Test <\/div>\n
\n View Press Release\n <\/div>\n
\n 12\/06\/2021 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Receives New York State Approval for Galleri Multi-Cancer Early Detection Blood Test <\/div>\n
\n View Press Release\n <\/div>\n
\n 09\/20\/2021 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
NHS Launches UK Trial of the Galleri Multi-Cancer Early Detection Blood Test <\/div>\n
\n View Press Release\n <\/div>\n
\n 09\/12\/2021 <\/div>\n <\/div>\n <\/a>\n \n <\/div>\n
\n \n
\n \"Img\"\n <\/div>\n
\n
Illumina Acquires GRAIL to Accelerate Patient Access to Life-Saving Multi-Cancer Early-Detection Test <\/div>\n
\n View Press Release\n <\/div>\n
\n 08\/18\/2021 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Presents Interventional PATHFINDER Study Data at 2021 ASCO Annual Meeting and Introduces Galleri, a Groundbreaking Multi-Cancer Early Detection Blood Test <\/div>\n
\n View Press Release\n <\/div>\n
\n 06\/04\/2021 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
Statement on the Passing of Dr. Jos\u00e9 Baselga, from his friends at GRAIL <\/div>\n
\n View Press Release\n <\/div>\n
\n 03\/21\/2021 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL, AccessHope Collaborate to Optimize Patient and Healthcare Provider Experience for Galleri, First-of-Kind Multi-Cancer Early Detection Blood Test <\/div>\n
\n View Press Release\n <\/div>\n
\n 03\/16\/2021 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Announces First Health System to Offer Galleri, Novel Multi-Cancer Early Detection Blood Test <\/div>\n
\n View Press Release\n <\/div>\n
\n 03\/02\/2021 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
Multi-Cancer Early Detection Company GRAIL Now Hiring For State-Of-The-Art Laboratory Facility in Research Triangle Park <\/div>\n
\n View Press Release\n <\/div>\n
\n 02\/25\/2021 <\/div>\n <\/div>\n <\/a>\n \n <\/div>\n
\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL and Quest Diagnostics Announce Collaboration to Support\u00a0Galleri, First-of-Kind Multi-Cancer Early Detection Blood Test\u00a0\u00a0 <\/div>\n
\n View Press Release\n <\/div>\n
\n 02\/23\/2021 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Announces Collaborations with Amgen, AstraZeneca, and Bristol Myers Squibb to Evaluate Cancer Early Detection Technology for Minimal Residual Disease <\/div>\n
\n View Press Release\n <\/div>\n
\n 01\/11\/2021 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Confirms Q2 2021 Introduction of Galleri, First-of-Kind Multi-Cancer Early Detection Blood Test <\/div>\n
\n View Press Release\n <\/div>\n
\n 01\/11\/2021 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
New Research Suggests Multi-Cancer Early Detection Blood Test Could Reduce Late-Stage Cancer Diagnoses by More Than Half <\/div>\n
\n View Press Release\n <\/div>\n
\n 12\/16\/2020 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL and UK Government to Make Galleri Multi-Cancer Early Detection Blood Test Available to Patients <\/div>\n
\n View Press Release\n <\/div>\n
\n 11\/26\/2020 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
Illumina to Acquire GRAIL to Launch New Era of Cancer Detection <\/div>\n
\n View Press Release\n <\/div>\n
\n 09\/21\/2020 <\/div>\n <\/div>\n <\/a>\n \n <\/div>\n
\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Announces Filing of Registration Statement for Proposed Initial Public Offering <\/div>\n
\n View Press Release\n <\/div>\n
\n 09\/09\/2020 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
Cleveland Clinic Joins Interventional Study Using GRAIL’s Multi-Cancer Early Detection Test to Help Guide Clinical Care <\/div>\n
\n View Press Release\n <\/div>\n
\n 08\/06\/2020 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL to Present New Data Supporting its Multi-Cancer Early Detection Test at the American Association for Cancer Research (AACR) Annual Meeting II <\/div>\n
\n View Press Release\n <\/div>\n
\n 06\/22\/2020 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Stands Against Injustice and Racism <\/div>\n
\n View Press Release\n <\/div>\n
\n 06\/06\/2020 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
NC Gov. Cooper: Governor Cooper Announces Nearly 400 New Jobs in Durham as Multi-Cancer Early Detection Company Chooses New Laboratory Location <\/div>\n
\n View Press Release\n <\/div>\n
\n 06\/02\/2020 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL to Participate in BofA Securities 2020 Health Care Conference <\/div>\n
\n View Press Release\n <\/div>\n
\n 05\/07\/2020 <\/div>\n <\/div>\n <\/a>\n \n <\/div>\n
\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Announces $390 Million Series D Financing <\/div>\n
\n View Press Release\n <\/div>\n
\n 05\/06\/2020 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
Mostafa Ronaghi Joins GRAIL\u2019s Board of Directors <\/div>\n
\n View Press Release\n <\/div>\n
\n 05\/04\/2020 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Appoints Satnam Alag as Senior Vice President of Software Engineering <\/div>\n
\n View Press Release\n <\/div>\n
\n 04\/29\/2020 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL to Present New Data at the American Association for Cancer Research (AACR) Annual Meeting <\/div>\n
\n View Press Release\n <\/div>\n
\n 04\/26\/2020 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Appoints Sir Harpal Kumar as President of GRAIL Europe <\/div>\n
\n View Press Release\n <\/div>\n
\n 04\/10\/2020 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Announces Validation of its Multi-Cancer Early Detection Test Published in Annals of Oncology <\/div>\n
\n View Press Release\n <\/div>\n
\n 03\/30\/2020 <\/div>\n <\/div>\n <\/a>\n \n <\/div>\n
\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Initiates First Interventional Study Using its Multi-Cancer Early Detection Test to Guide Clinical Care <\/div>\n
\n View Press Release\n <\/div>\n
\n 02\/18\/2020 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Appoints Gautam Kollu as Chief Commercial Officer <\/div>\n
\n View Press Release\n <\/div>\n
\n 12\/16\/2019 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Appoints Matthew Young as Chief Operating Officer and Chief Financial Officer <\/div>\n
\n View Press Release\n <\/div>\n
\n 10\/07\/2019 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Announces Positive Validation Data for its Multi-Cancer Early Detection Test <\/div>\n
\n View Press Release\n <\/div>\n
\n 10\/07\/2019 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Appoints Marissa Song as General Counsel and Corporate Secretary <\/div>\n
\n View Press Release\n <\/div>\n
\n 09\/30\/2019 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL to Present New Data in Late-Breaking Oral Presentation at the European Society for Medical Oncology (ESMO) 2019 Congress <\/div>\n
\n View Press Release\n <\/div>\n
\n 09\/27\/2019 <\/div>\n <\/div>\n <\/a>\n \n <\/div>\n
\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Appoints Rodger Currie as Head of Government Affairs and Alliance Development <\/div>\n
\n View Press Release\n <\/div>\n
\n 08\/26\/2019 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Announces Appointment of Hans Bishop as Chief Executive Officer and Strengthens Leadership Team and Board of Directors with New Appointments <\/div>\n
\n View Press Release\n <\/div>\n
\n 06\/06\/2019 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Announces Positive New Data with Multi-Cancer Early Detection Blood Test from CCGA Study <\/div>\n
\n View Press Release\n <\/div>\n
\n 05\/31\/2019 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Announces Promising New Data with Early Detection Blood Test to be Presented at 2019 American Society of Clinical Oncology Annual Meeting <\/div>\n
\n View Press Release\n <\/div>\n
\n 05\/15\/2019 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Announces Significant Progress with Multi-Cancer Early Detection Test Including FDA Breakthrough Device Designation <\/div>\n
\n View Press Release\n <\/div>\n
\n 05\/13\/2019 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Announces Appointment of Catherine Friedman as Chair of GRAIL Board <\/div>\n
\n View Press Release\n <\/div>\n
\n 12\/10\/2018 <\/div>\n <\/div>\n <\/a>\n \n <\/div>\n
\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Announces Plans to Initiate SUMMIT Study to Support Development of Blood Test for Early Cancer Detection <\/div>\n
\n View Press Release\n <\/div>\n
\n 12\/03\/2018 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL to Present New Data from the Circulating Cell-free Genome Atlas (CCGA) Study at the European Society for Medical Oncology (ESMO) 2018 Congress <\/div>\n
\n View Press Release\n <\/div>\n
\n 10\/19\/2018 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Announces Appointment of Ren\u00e9e Gal\u00e1 as Chief Financial Officer <\/div>\n
\n View Press Release\n <\/div>\n
\n 10\/04\/2018 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Announces Appointment of Hal Barron and Hans Bishop to its Board of Directors <\/div>\n
\n View Press Release\n <\/div>\n
\n 08\/09\/2018 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Announces Appointment of Key Executives as Company Makes Continued Progress in Development of Early Detection Products <\/div>\n
\n View Press Release\n <\/div>\n
\n 07\/09\/2018 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Announces Data on Detection of Early-Stage Lung Cancers <\/div>\n
\n View Press Release\n <\/div>\n
\n 06\/02\/2018 <\/div>\n <\/div>\n <\/a>\n \n <\/div>\n
\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Announces $300 Million Raised in Oversubscribed Series C Financing <\/div>\n
\n View Press Release\n <\/div>\n
\n 05\/21\/2018 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL to Present New Data from Circulating Cell-free Genome Atlas (CCGA) Study at 2018 American Society of Clinical Oncology Annual Meeting <\/div>\n
\n View Press Release\n <\/div>\n
\n 05\/16\/2018 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Announces Data from Prototype Blood Tests for Early Cancer Detection <\/div>\n
\n View Press Release\n <\/div>\n
\n 04\/17\/2018 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Announces Appointment of Jennifer Cook as Chief Executive Officer <\/div>\n
\n View Press Release\n <\/div>\n
\n 12\/14\/2017 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Appoints Chairman Bill Rastetter to Chief Executive Officer <\/div>\n
\n View Press Release\n <\/div>\n
\n 08\/02\/2017 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Announces Data From Early Research Analyzing its High-Intensity Sequencing Approach <\/div>\n
\n View Press Release\n <\/div>\n
\n 06\/03\/2017 <\/div>\n <\/div>\n <\/a>\n \n <\/div>\n
\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Announces Board of Directors Appointments <\/div>\n
\n View Press Release\n <\/div>\n
\n 05\/04\/2017 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Initiates the STRIVE Study to Advance Development of Blood Tests to Detect Cancer Early <\/div>\n
\n View Press Release\n <\/div>\n
\n 04\/20\/2017 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL and Cirina Combine to Create Global Company Focused on Early Detection of Cancer <\/div>\n
\n View Press Release\n <\/div>\n
\n 03\/31\/2017 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Closes Over $900 Million Initial Investment in Series B Financing to Develop Blood Tests to Detect Cancer Early <\/div>\n
\n View Press Release\n <\/div>\n
\n 03\/01\/2017 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Plans to Raise in Excess of $1B in Series B Funding <\/div>\n
\n View Press Release\n <\/div>\n
\n 01\/05\/2017 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Announces Circulating Cell-free Genome Atlas (CCGA) Study as Foundation for Development of Blood Test to Detect Cancer Early <\/div>\n
\n View Press Release\n <\/div>\n
\n 12\/01\/2016 <\/div>\n <\/div>\n <\/a>\n \n <\/div>\n
\n \n
\n \"Img\"\n <\/div>\n
\n
GRAIL Hires Google Executive Jeff Huber as CEO to Lead Development for Early Cancer Detection <\/div>\n
\n View Press Release\n <\/div>\n
\n 02\/10\/2016 <\/div>\n <\/div>\n <\/a>\n \n
\n \"Img\"\n <\/div>\n
\n
Illumina Forms New Company to Enable Early Cancer Detection via Blood-Based Screening <\/div>\n
\n View Press Release\n <\/div>\n
\n 01\/10\/2016 <\/div>\n <\/div>\n <\/a>\n \n <\/div>\n \n
\n <\/g><\/svg>\n <\/g><\/svg>\n <\/div>
\n <\/svg>\n <\/svg>\n <\/div>
<\/div>
<\/div>
\n <\/svg>\n <\/svg>\n <\/div>
\n <\/g><\/svg>\n <\/g><\/svg>\n <\/div><\/div> <\/div>\n <\/div>\n \n <\/div>\n <\/div>\n <\/div>\n <\/div>\n\n\n\n\n
\n
\n
<\/div>\n <\/div>\n <\/div>\n\n\n\n
\n

Contact us<\/p>\n

1525 O’Brien Drive Menlo Park, CA 94025 | (833)-694-2553<\/p>\n<\/p>\n Get in touch<\/span>Get in touch<\/span><\/a> <\/div>\n","protected":false},"excerpt":{"rendered":"

Press Releases<\/p>\n","protected":false},"author":7,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-3769","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"\nPress Releases - GRAIL<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/grail.com\/press-releases\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Press Releases - GRAIL\" \/>\n<meta property=\"og:description\" content=\"Press Releases\" \/>\n<meta property=\"og:url\" content=\"https:\/\/grail.com\/press-releases\/\" \/>\n<meta property=\"og:site_name\" content=\"GRAIL\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/grailbio\/\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-17T22:22:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/assets.grail.com\/wp-content\/uploads\/2020\/12\/logo%402x.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"423\" \/>\n\t<meta property=\"og:image:height\" content=\"172\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@grailbio\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/grail.com\/press-releases\/\",\"url\":\"https:\/\/grail.com\/press-releases\/\",\"name\":\"Press Releases - GRAIL\",\"isPartOf\":{\"@id\":\"https:\/\/grail.com\/#website\"},\"datePublished\":\"2023-07-21T23:55:25+00:00\",\"dateModified\":\"2025-10-17T22:22:46+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/grail.com\/press-releases\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/grail.com\/press-releases\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/grail.com\/press-releases\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/grail.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Press Releases\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/grail.com\/#website\",\"url\":\"https:\/\/grail.com\/\",\"name\":\"GRAIL\",\"description\":\"Detect cancer early, when it can be cured\",\"publisher\":{\"@id\":\"https:\/\/grail.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/grail.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/grail.com\/#organization\",\"name\":\"GRAIL, LLC\",\"url\":\"https:\/\/grail.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/grail.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/assets.grail.com\/wp-content\/uploads\/2021\/01\/cropped-favicon-G.png\",\"contentUrl\":\"https:\/\/assets.grail.com\/wp-content\/uploads\/2021\/01\/cropped-favicon-G.png\",\"width\":512,\"height\":512,\"caption\":\"GRAIL, LLC\"},\"image\":{\"@id\":\"https:\/\/grail.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/grailbio\/\",\"https:\/\/x.com\/grailbio\",\"https:\/\/www.linkedin.com\/company\/grail-inc.\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Press Releases - GRAIL","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/grail.com\/press-releases\/","og_locale":"en_US","og_type":"article","og_title":"Press Releases - GRAIL","og_description":"Press Releases","og_url":"https:\/\/grail.com\/press-releases\/","og_site_name":"GRAIL","article_publisher":"https:\/\/www.facebook.com\/grailbio\/","article_modified_time":"2025-10-17T22:22:46+00:00","og_image":[{"width":423,"height":172,"url":"https:\/\/assets.grail.com\/wp-content\/uploads\/2020\/12\/logo%402x.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@grailbio","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/grail.com\/press-releases\/","url":"https:\/\/grail.com\/press-releases\/","name":"Press Releases - GRAIL","isPartOf":{"@id":"https:\/\/grail.com\/#website"},"datePublished":"2023-07-21T23:55:25+00:00","dateModified":"2025-10-17T22:22:46+00:00","breadcrumb":{"@id":"https:\/\/grail.com\/press-releases\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/grail.com\/press-releases\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/grail.com\/press-releases\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/grail.com\/"},{"@type":"ListItem","position":2,"name":"Press Releases"}]},{"@type":"WebSite","@id":"https:\/\/grail.com\/#website","url":"https:\/\/grail.com\/","name":"GRAIL","description":"Detect cancer early, when it can be cured","publisher":{"@id":"https:\/\/grail.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/grail.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/grail.com\/#organization","name":"GRAIL, LLC","url":"https:\/\/grail.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/grail.com\/#\/schema\/logo\/image\/","url":"https:\/\/assets.grail.com\/wp-content\/uploads\/2021\/01\/cropped-favicon-G.png","contentUrl":"https:\/\/assets.grail.com\/wp-content\/uploads\/2021\/01\/cropped-favicon-G.png","width":512,"height":512,"caption":"GRAIL, LLC"},"image":{"@id":"https:\/\/grail.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/grailbio\/","https:\/\/x.com\/grailbio","https:\/\/www.linkedin.com\/company\/grail-inc.\/"]}]}},"_links":{"self":[{"href":"https:\/\/grail.com\/wp-json\/wp\/v2\/pages\/3769","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/grail.com\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/grail.com\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/grail.com\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/grail.com\/wp-json\/wp\/v2\/comments?post=3769"}],"version-history":[{"count":9,"href":"https:\/\/grail.com\/wp-json\/wp\/v2\/pages\/3769\/revisions"}],"predecessor-version":[{"id":7428,"href":"https:\/\/grail.com\/wp-json\/wp\/v2\/pages\/3769\/revisions\/7428"}],"wp:attachment":[{"href":"https:\/\/grail.com\/wp-json\/wp\/v2\/media?parent=3769"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}